Veerhealth Care Ltd
Veerhealth Care Ltd (VEERHEALTH) last reported results for the quarter ended Jun 2026, with sales of ₹24.93 crore and net profit of ₹1.23 crore. The stock last traded at ₹49.6, a market capitalisation of ₹99.1 crore, on a P/E of 75.7. Over the past 52 weeks the stock has ranged between ₹16.7 and ₹52. Figures are as of 9 Oct 2026 and are not real time.
Veerhealth Care Ltd share price and key metrics
- Current price
- ₹49.6
- Market cap
- ₹99.1 cr
- Stock P/E
- 75.7
- Book value
- ₹11.5
- ROE
- 2.97%
- ROCE
- 7.21%
- Dividend yield
- 0.00%
- 52w high / low
- 52.0/16.7
Metrics as of 9 Oct 2026. Not real time.
Track Veerhealth Care Ltd
Cruxal reads every Veerhealth Care Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Veerhealth Care Ltd growth and returns
- 10 Years
- 31%
- 5 Years
- 25%
- 3 Years
- 35%
- TTM
- 177%
- 10 Years
- 52%
- 5 Years
- 12%
- 3 Years
- -25%
- TTM
- 157%
- 10 Years
- 20%
- 5 Years
- 55%
- 3 Years
- 36%
- 1 Year
- 169%
- 10 Years
- 2%
- 5 Years
- 3%
- 3 Years
- 2%
- Last Year
- 3%
Veerhealth Care Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹24.93 cr, up 455.2% from ₹4.49 cr a year earlier. Net profit was ₹1.23 cr, up 412.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5.15 | 3.84 | 5.62 | 4.49 | 3.98 | 7.26 | 16.76 | 24.93 |
| Expenses | 4.67 | 3.69 | 5.78 | 4.52 | 3.45 | 6.02 | 16.03 | 23.02 |
| Operating profit | 0.48 | 0.15 | -0.16 | -0.03 | 0.53 | 1.24 | 0.73 | 1.91 |
| OPM % | 9.32% | 3.91% | -2.85% | -0.67% | 13.32% | 17.08% | 4.36% | 7.66% |
| Other income | 0.25 | 0.18 | 0.43 | 0.65 | 0.23 | -0.29 | -0.09 | 0.16 |
| Interest | 0.11 | 0.01 | 0.14 | 0.1 | 0.1 | 0.1 | 0.11 | 0.23 |
| Depreciation | 0.2 | 0.25 | 0.26 | 0.28 | 0.31 | 0.35 | 0.35 | 0.36 |
| Profit before tax | 0.42 | 0.07 | -0.13 | 0.24 | 0.35 | 0.5 | 0.18 | 1.48 |
| Tax % | 28.57% | 0.00% | -23.08% | 0.00% | 25.71% | 18.00% | 294.44% | 16.89% |
| Net profit | 0.3 | 0.07 | -0.1 | 0.24 | 0.25 | 0.4 | -0.35 | 1.23 |
| EPS (₹) | 0.15 | 0.04 | -0.05 | 0.12 | 0.13 | 0.20 | -0.18 | 0.62 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Veerhealth Care Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.89 | 5.17 | 5.98 | 11.72 | 10.62 | 9.64 | 13.28 | 13.22 | 16.87 | 32.48 | 52.93 |
| Operating profit | -0.36 | -0.12 | 0.44 | 0.68 | 0.06 | -0.82 | 0.5 | 0.61 | 0.77 | 2.46 | 4.41 |
| OPM % | -19.05% | -2.32% | 7.36% | 5.80% | 0.56% | -8.51% | 3.77% | 4.61% | 4.56% | 7.57% | 8.33% |
| Net profit | 0.02 | 0.14 | 0.16 | 0.32 | 0.38 | -0.07 | 1.58 | 0.41 | 0.39 | 0.54 | 1.53 |
| EPS (₹) | 0.01 | 0.10 | 0.12 | 0.23 | 0.27 | -0.05 | 0.79 | 0.21 | 0.20 | 0.27 | 0.77 |
TTM is the trailing twelve months to the most recent quarter.
Veerhealth Care Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 10.00 | 20.00 | 20.00 | 20.00 |
| Reserves | 5.92 | 6.17 | 6.35 | 6.82 | 7.11 | 7.02 | 11.43 | 1.84 | 2.22 | 2.92 |
| Borrowings | -0.17 | 1.21 | 0.94 | 2.48 | 1.73 | 0.00 | 0.00 | 0.00 | 4.91 | 4.58 |
| Other liabilities | 0.37 | 0.42 | 1.94 | 1.76 | 2.96 | 6.20 | 3.82 | 6.28 | 6.65 | 16.67 |
| Total liabilities | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 33.78 | 44.17 |
| Fixed assets | 2.52 | 5.54 | 5.46 | 9.45 | 9.48 | 10.54 | 12.01 | 11.97 | 19.87 | 23.43 |
| CWIP | 0.00 | 0.24 | 2.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 10.53 | 8.95 | 8.51 | 8.54 | 9.25 | 9.61 | 13.24 | 16.15 | 13.91 | 20.74 |
| Total assets | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 33.78 | 44.17 |
As reported by the company. Total assets equal total liabilities by construction.
Veerhealth Care Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1.69 | 1.76 | 1.98 | -0.36 | 1.00 | 1.81 | -0.70 | 2.90 | 4.51 | 4.19 |
| Cash from investing | -0.44 | -3.02 | -1.90 | -1.67 | -0.09 | -1.09 | -1.79 | -0.28 | -8.20 | -4.43 |
| Cash from financing | -1.33 | 1.31 | 0.02 | 1.85 | -0.83 | -0.42 | 5.69 | -5.99 | 4.61 | -0.46 |
| Net cash flow | -0.08 | 0.06 | 0.10 | -0.17 | 0.09 | 0.30 | 3.21 | -3.37 | 0.92 | -0.70 |
| Free cash flow | 1.66 | -1.78 | -0.21 | -2.48 | 0.50 | 0.23 | -2.79 | 2.22 | -4.30 | -0.67 |
| CFO / operating profit | -253% | -1,550% | 480% | -44% | 2,050% | -226% | -100% | 523% | 597% | 179% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Veerhealth Care Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 0.98% | 2.45% | 2.87% | 5.52% | 4.94% | 2.22% | 6.33% | 5.96% | 3.59% | 7.21% |
| Debtor days | 117.80 | 64.95 | 45.17 | 29.27 | 52.93 | 58.31 | 50.57 | 108.23 | 21.20 | 109.46 |
| Inventory days | 477.31 | 93.49 | 77.82 | 54.35 | 76.21 | 102.76 | 103.21 | 55.97 | 78.12 | 67.26 |
| Days payable | 68.63 | 18.90 | 145.44 | 37.12 | 42.24 | 112.46 | 21.75 | 86.35 | 83.89 | 183.18 |
| Cash conversion cycle | 526.48 | 139.54 | -22.46 | 46.51 | 86.90 | 48.61 | 132.03 | 77.85 | 15.44 | -6.47 |
| Working capital days | 1,597.12 | 393.95 | 8.55 | 145.44 | 177.34 | 127.60 | 158.31 | 288.52 | 85.25 | 51.24 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Veerhealth Care Ltd shareholding pattern
Promoters held 31.91% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 30.41% | 30.41% | 31.50% | 31.50% | 31.50% | 31.50% | 31.50% | 31.91% |
| Public | 69.59% | 69.59% | 68.49% | 68.50% | 68.50% | 68.50% | 68.50% | 68.10% |
| No. of shareholders | 11,489 | 11,469 | 11,390 | 11,011 | 10,846 | 10,455 | 10,027 | 9,315 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Veerhealth Care Ltd corporate filings
- Please find the attached herewith disclosure for Regulation 74(5) of SEBI DP Regulations for Quarter ended 30.09.2026Company Updatelow impact
- Veerhealth Care Ltd. Receives Order Worth Rs. 454.68 Lakhs from FMCG Company, Indicating Potential Revenue UpsideCompany Updatehigh impact
Cruxal's analysis: Veerhealth Care Ltd. has announced the receipt of a significant order valued at Rs…
Read the full analysis - Intimation of trading window closureInsider Trading / SASTlow impact
- Veerhealth Care Ltd Announces Successful Passing of Resolutions at 34th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Veerhealth Care Ltd has successfully concluded its 34th Annual General Meeting held on…
Read the full analysis - Veerhealth Care Ltd. Concludes 34th Annual General Meeting with Routine Business AdoptionAGM/EGMlow impact
Cruxal's analysis: Veerhealth Care Ltd. has successfully concluded its 34th Annual General Meeting (AGM)…
Read the full analysis - Veerhealth Care Ltd. issues corrigendum regarding timing of 34th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Veerhealth Care Ltd. has issued a formal corrigendum to correct a typographical error in…
Read the full analysis - Veerhealth Care secures strategic MoU with Indo-Canadian JV for oral care products, projects significant revenue growthCompany Updatehigh impact
Cruxal's analysis: Veerhealth Care Limited has received a sample order worth 10.07 lakh and signed a…
Read the full analysis - Veerhealth Care Ltd. Secures Supply Agreement and Initial Order Worth INR 10.07 LakhCompany Updatemedium impact
Cruxal's analysis: Veerhealth Care Ltd. has entered into a supply agreement with an Indo-Canadian joint…
Read the full analysis - Veerhealth Care Secures Monthly Repeat Order Worth INR 4.36 Crore and Provides Aggressive Forward-Looking Financial GuidanceCompany Updatehigh impact
Cruxal's analysis: Veerhealth Care Limited has announced a monthly repeat order valued at INR 4.36 crore for…
Read the full analysis - Veerhealth Care Ltd. Secures Domestic Order for Skincare Products Valued at 4.37 Crore INRCompany Updatehigh impact
Cruxal's analysis: Veerhealth Care Ltd. has announced the receipt of a domestic order for the supply of face…
Read the full analysis - Enclosing herewith the advertisement published in newspaper on 01st September, 2026 regarding 34th AGM, book closure and evoting.Company Updatemedium impact
- Veerhealth Care Ltd issues routine communication to shareholdersCompany Updatelow impact
Cruxal's analysis: Veerhealth Care Ltd has released a letter addressed to its shareholders. The disclosure…
Read the full analysis - VeerHealth Care Limited Reports Strong Revenue Growth and Operational Expansion in FY 2025-26 Annual ReportAGM/EGMhigh impact
Cruxal's analysis: VeerHealth Care Limited has released its 34th Annual Report for FY 2025-26, highlighting…
Read the full analysis - Veerhealth Care Ltd releases Annual Report for the financial year 2025-2026Otherslow impact
Cruxal's analysis: Veerhealth Care Ltd has filed its Annual Report for the financial year 2025-2026 as per…
Read the full analysis - Veerhealth Care Ltd publishes routine newspaper notice under Regulation 30Company Updatelow impact
Cruxal's analysis: Veerhealth Care Ltd has released a newspaper publication in compliance with Regulation 30…
Read the full analysis - Veerhealth Care Ltd releases routine press release under Regulation 30Company Updatelow impact
Cruxal's analysis: Veerhealth Care Ltd has filed a press release under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Veerhealth Care Ltd. Reports Strong Q1 FY27 Financials with 48.7% Revenue Growth and Significant Profit TurnaroundResulthigh impact
Cruxal's analysis: Veerhealth Care Ltd. delivered robust financial results for the quarter ended June 30…
Read the full analysis - Veerhealth Care secures monthly repeat order worth 5.27 crore and provides aggressive forward-looking financial guidanceCompany Updatehigh impact
Cruxal's analysis: Veerhealth Care Limited has announced a monthly repeat order valued at 5.27 crore from a…
Read the full analysis - Veerhealth Care Limited schedules Board Meeting for August 13, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Veerhealth Care Limited has issued a formal notice for a Board of Directors meeting…
Read the full analysis - Veerhealth Care Secures INR 5.27 Crore Skincare Product Order from Major Indian FMCG Player, Boosting Turnover OutlookCompany Updatehigh impact
Cruxal's analysis: Veerhealth Care Ltd. has announced the receipt of a significant order worth INR 5.2684…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.